Featured Image for VirgoCX Direct Inc.
VirgoCX Wealth to Launch Anticipated OTC Direct Upgrade
20 oct. 2022 15h00 HE | VirgoCX Direct Inc.
TORONTO, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Canada's leading regulated cryptocurrency exchange VirgoCX is set to launch the anticipated OTC Direct overhaul to its over-the-counter (OTC) trading...
Straits Research Pvt Ltd
OTC Artificial Tears Market Size is projected to reach USD 6.79 Billion by 2030, growing at a CAGR of 5.10%: Straits Research
18 août 2022 10h30 HE | Straits Research
New York, United States, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The application of artificial tears protects and hydrates mucous membranes and alleviates dryness and irritation of the eyes. Artificial...
Mid-Size Pharmaceutical Market Size Hit $1000.5 Bn Globally, by 2028 at 6.4% CAGR during 2022–2028 - Exclusive Report by The Insight Partners
15 juil. 2022 07h30 HE | The Insight Partners
New York, July 15, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Mid-Size Pharmaceutical Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type,...
Cover of the 2022 edition of The OTC Guide®, published by Pharmacy Times®
U.S. News & World Report and Pharmacy Times® Reveal Top-Recommended Health Products in the 2022 Edition of The OTC Guide®
13 juin 2022 09h27 HE | Pharmacy Times®
CRANBURY, N.J. and WASHINGTON, June 13, 2022 (GLOBE NEWSWIRE) -- U.S. News & World Report, the global authority in rankings and consumer advice, and Pharmacy Times®, the leading multimedia...
ARC logo.png
Over-the-Counter (OTC) Drugs Market Value Forecasted To Reach US$ 208.9 Billion By 2027: Acumen Research and Consulting
31 mars 2021 11h15 HE | Acumen Research and Consulting
LOS ANGELES, March 31, 2021 (GLOBE NEWSWIRE) -- The Global Over-the-Counter (OTC) Drugs Market is expected to grow at a CAGR of around 5.2% from 2020 to 2027 and reach the market value of over US$...
AMR Logo.png
Topical Pain Relief Market Size to Reach $12.21 Billion, Globally, by 2027 at 5.2% CAGR: Allied Market Research
25 mars 2021 08h50 HE | Allied Market Research
Portland, OR, March 25, 2021 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Topical Pain Relief Market by Therapeutic Class (Non-Opioids and Opioids), Formulation (Cream,...
ProPhase Announces Change in Tax Treatment of 2018 Dividends
09 avr. 2019 16h57 HE | ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, April 09, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) announced a change in the reporting of dividends paid to its stockholders in...
26 déc. 2018 09h15 HE | ProPhase Labs, Inc.
DOYLESTOWN, PA, Dec. 26, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a vertically integrated manufacturer, marketer and distributor of a diversified range of...
ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2018
14 nov. 2018 07h30 HE | ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 14, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported its financial results for the three and nine months ended...
IMC Logo.jpg
Travelan® Revenue Grows Significantly in US and Australia
16 févr. 2018 09h30 HE | Immuron Limited
Key Highlights: Immuron’s flagship product Travelan® reports revenue in excess of AUS$914K for first 6mths of FY2018  Travelan® US experienced a 250% increase in sales year over year reaching...